Document is current
Any future updates will be listed below
-
Authors
Doyle, S.
Oerlemans, M. A.
Brunekreef, J.
Marcus, E.
Mulder, L.
Liu, Y.
Bouybayoune, I.
Sawyer, E. J.
Thompson, A. M.
Pinder, S. E.
,
Wesseling, Jelle
Thompson, Alastair
Nik-Zainal, Serena
Sawyer, Elinor J.
Davies, Helen
Futreal, Andrew
Navin, Nicholas
Hwang, E. Shelley
Jonkers, Jos
van Rheenen, Jacco
Behbod, Fariba
Lips, Esther H.
Schmidt, Marjanka
Wessels, Lodewyk F. A.
Rea, Daniel
Bhattacharjee, Proteeti
Stobart, Hilary
Collyar, Deborah
Pinto, Donna
Verschuur, Ellen
van Oirsouw, Marja
Wesseling, Jelle
Thompson, Alastair
Nik-Zainal, Serena
Sawyer, Elinor J.
Davies, Helen
Futreal, Andrew
Navin, Nicholas
Hwang, E. Shelley
Jonkers, Jos
van Rheenen, Jacco
Behbod, Fariba
Lips, Esther H.
Schmidt, Marjanka
Wessels, Lodewyk F. A.
Rea, Daniel
Bhattacharjee, Proteeti
Stobart, Hilary
Collyar, Deborah
Pinto, Donna
Verschuur, Ellen
van Oirsouw, Marja
Sánchez, C. I.
Teuwen, J.
Wesseling, J.
Lips, E. H.
-
Funding
Funding for this research was provided by:
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
Cancer Research, UK (C38317/A24043)
KWF Kankerbestrijding (14036)
KWF Kankerbestrijding (14036)
KWF Kankerbestrijding (14036)
KWF Kankerbestrijding (14036)
KWF Kankerbestrijding (14036)
KWF Kankerbestrijding (14036)
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 24 April 2026
First Online: 6 May 2026
Competing interests
: J.T. declares being a share owner of Glass Medical AI BV; consulting for ScreenPoint Medical (all active). J.T. received support to attend II-ON BMS conference. J.T. is also a member of the Dutch Cancer Foundation KWF – Smart Measurement committee, as well as Dutch organization for scientific research—Veni Committee. J.T. is Associate Editor of NPJ Breast Cancer. J.T. was not involved in the journal’s review of, or decisions related to, this manuscript. The other authors do not have a competing interest. The consortium was funded by Cancer Grand Challenges, an initiative from Cancer Research UK and the National Cancer Institute, under project Cancer Grand Challenge PRECISION (C38317/A24043).
